NCT03848156View on ClinicalTrials.gov

Characterisation of Nasal Polyps in Patients With and Without Aspirin-exacerbated Respiratory Disease

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Polyp Sinus
Interventions
OTHER

biopsy

Biopsy of nasal polyp for RNA sequencing

Trial Locations (1)

1090

Medical University of Vienna, Vienna

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Medical University of Vienna

OTHER